Medivation Announces Participation in Upcoming Conferences

Record Date: 9/8/2010
Company: Medivation

SAN FRANCISCO, March 1, 2010 -- Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the following conferences:

- The Cowen Healthcare Conference, Monday, March 8, at 4:45 p.m. Eastern Time at the Marriott Copley Place Hotel in Boston

- The ROTH 22nd Annual OC Growth Stock Conference, on Tuesday, March 16, at 12:30 p.m. Pacific Time at the Ritz-Carlton in Dana Point, Calif.

Dr. Hung will provide an overview of Medivation and its clinical development programs including dimebon (latrepirdine) for Alzheimer's and Huntington diseases and MDV3100 for prostate cancer.

A live audio webcast of each presentation will be available on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at http://www.medivation.com. A replay also will be available for 30 days following the live presentation.